Literature DB >> 16911640

Human papillomavirus and head and neck cancer: a systematic review and meta-analysis.

C G L Hobbs1, J A C Sterne, M Bailey, R S Heyderman, M A Birchall, S J Thomas.   

Abstract

It has been suggested that the link between human papillomavirus (HPV) and head and neck squamous cell carcinoma (HNSCC) is specific to carcinoma of the tonsil. We systematically reviewed studies that tested for HPV16 exposure in anatomically defined sites in the head and neck and a control group. The association between HPV16 and cancer was strongest for tonsil (OR: 15.1, 95% CI: 6.8-33.7), intermediate for oropharynx (OR: 4.3, 95% CI: 2.1-8.9) and weakest for oral (OR: 2.0, 95% CI: 1.2-3.4) and larynx (OR: 2.0, 95% CI: 1.0-4.2). To investigate heterogeneity, further stratification by method of HPV16 detection, suggested that variation in the magnitude of the HPV-cancer association with cancer site was restricted to studies using ELISA: among studies using PCR, the magnitude of the summary odds ratios was similar across the four sites. The association between HPV16 infection and HNSCC in specific sites suggests the strongest and most consistent association is with tonsil cancer, and the magnitude of this association is consistent with an infectious aetiology. However, the method of viral detection may be an important source of heterogeneity. Resolution of this issue will require further studies using both methods, examining associations separately in different sites.

Entities:  

Mesh:

Year:  2006        PMID: 16911640     DOI: 10.1111/j.1749-4486.2006.01246.x

Source DB:  PubMed          Journal:  Clin Otolaryngol        ISSN: 1749-4478            Impact factor:   2.597


  85 in total

Review 1.  The role of HPV in head and neck cancer and review of the HPV vaccine.

Authors:  Gypsyamber D'Souza; Amanda Dempsey
Journal:  Prev Med       Date:  2011-10       Impact factor: 4.018

2.  Head and neck squamous cell carcinomas in HIV-positive patients: a preliminary investigation of viral associations.

Authors:  Michael S McLemore; Missak Haigentz; Richard V Smith; Gerard J Nuovo; Llucia Alos; Antonio Cardesa; Margaret Brandwein-Gensler
Journal:  Head Neck Pathol       Date:  2010-03-24

3.  Severe prolonged dysphagia following transoral resection of bilateral synchronous tonsillar carcinoma.

Authors:  Alpen B Patel; Michael L Hinni; Taylor R Pollei; Richard E Hayden; Eric J Moore
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-02-08       Impact factor: 2.503

4.  Human papillomavirus 6 seropositivity is associated with risk of head and neck squamous cell carcinoma, independent of tobacco and alcohol use.

Authors:  C S Furniss; M D McClean; J F Smith; J Bryan; K M Applebaum; H H Nelson; M R Posner; K T Kelsey
Journal:  Ann Oncol       Date:  2008-12-15       Impact factor: 32.976

Review 5.  Head and neck cancer: an evolving treatment paradigm.

Authors:  David M Cognetti; Randal S Weber; Stephen Y Lai
Journal:  Cancer       Date:  2008-10-01       Impact factor: 6.860

Review 6.  Hoarseness-causes and treatments.

Authors:  Rudolf Reiter; Thomas Karl Hoffmann; Anja Pickhard; Sibylle Brosch
Journal:  Dtsch Arztebl Int       Date:  2015-05-08       Impact factor: 5.594

7.  The role of protein p16(INK4a) in glottic laryngeal squamous cell carcinoma.

Authors:  David Kalfert; Petr Celakovsky; Jan Laco; Marie Ludvikova
Journal:  Pathol Oncol Res       Date:  2014-04-24       Impact factor: 3.201

8.  Sex disparities in cancer incidence by period and age.

Authors:  Michael B Cook; Sanford M Dawsey; Neal D Freedman; Peter D Inskip; Sara M Wichner; Sabah M Quraishi; Susan S Devesa; Katherine A McGlynn
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-03-17       Impact factor: 4.254

9.  Improved survival with HPV among African Americans with oropharyngeal cancer.

Authors:  Maria J Worsham; Josena K Stephen; Kang Mei Chen; Meredith Mahan; Vanessa Schweitzer; Shaleta Havard; George Divine
Journal:  Clin Cancer Res       Date:  2013-03-26       Impact factor: 12.531

10.  Recurrence in oral and pharyngeal cancer is associated with quantitative MGMT promoter methylation.

Authors:  Emanuela Taioli; Camille Ragin; Xiao-Hong Wang; Jiangying Chen; Scott M Langevin; Ashley R Brown; Susanne M Gollin; Seymour Garte; Robert W Sobol
Journal:  BMC Cancer       Date:  2009-10-06       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.